Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate Treatment

NCT04754750 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenics

Interventions

DRUG: Paliperidone Palmitate 156 MG/ML Prefilled Syringe [Invega]
DRUG: Paliperidone Palmitate 546 MG Intramuscular Suspension, Extended Release [INVEGA TRINZA]

Sponsor

Calo Psychiatric Center